Josh Wolfe’s Post

I'm starting a company. We are building autonomous agents that can reason over the sum total of biomedical knowledge. Thousands of decisions behind breakthrough drugs—from experimental design to new product planning—can be augmented by this scientific intelligence. These are the tools I wish I had, after years of building and investing in therapeutics companies. Now, we are honored to partner with drug developers who have dedicated their careers to their craft. It is not easy to engineer useful software for those at the pinnacle of human expertise. But it will transform how life-saving discoveries are brought to patients. If this sounds like fun, reach out. We're hiring founding engineers.

TECHNOLOGY ITSELF IS NOT NECESSARILY GOOD OR BAD - IT DEPENDS ON THE BUSINESS MODEL This week on the Leaders In Innovation Podcast, I had the pleasure of chatting with polymath Josh Wolfe (Co-Founder and Managing Partner of Lux Capital). Josh is a truly visionary VC, with his ethics still firmly intact. Our conversation explored the vast landscape of innovation and felt like gazing into a crystal ball. One thought that's stuck with me is the moral valence of technology. As Josh put it "technology itself is not necessarily good or bad - it depends on the business model." Is the technology designed to sow discord or foster connection? The answer lies in the business models and incentives that power them. In the fast lane of AI, such critical questions arise. What virtues will propel these tools forward? As Josh believes it’s crucial that technology emerges from companies we trust — ones that are virtuously competitive. Loved having you on my friend (Josh Wolfe) 👊 Thank you for sharing such nuggets of wisdom 🧠 I just about kept up with your mad scientist brain! Hope you enjoy and please rate and subscribe if you’d like to hear more. Apple: https://lnkd.in/gTDNpViq Spotify: https://lnkd.in/gGFcHSCD #leadersininnovation  #ai #technology